The gum was designed by Dr. Henry Daniell, a researcher at the Penn School of Dental Medicine, and was created using plant-based materials that lock up a protein found in COVID-19, according to a Sept. 8 news release.
The trial will recruit 40 Penn Dental employees who recently had COVID-19 symptoms.
If found to be effective, the gum could make it safer for dentists to provide dental and oral care to patients who test positive, according to the release.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
